You are here

Mesenchymal Stem Cells

Comment

Discuss

Cell Volume modulates Mesenchymal Stem Cell Fate

Researchers studying microenvironmental influences on cell mechanics highlight a link between changes in cell volume and the differentiation potential of mesenchymal stem cells

 

Enhancing Cartilage Repair Strategies with ROR2

New research suggests that selecting MSCs based on inducible receptor tyrosine kinase-like orphan receptor 2 expression may lead to enhanced cartilage repair strategies

Organ-Specific “Tissue Papers” Created from Extracellular Matrix Ink

Researchers have developed a new means to utilize decellularized extracellular matrix in regenerative strategies including the maintenance of ovarian tissue 

Enhanced Bone Fracture Healing with Engineered Mesenchymal Stem Cells

The overexpression of basic fibroblast growth factor boosts bone fracture healing capacity of mesenchymal stem cells via the secretion of paracrine-acting factors

CAMKK1 Overexpression: A New and Effective Strategy to Improve Cardiac Repair?

A new study suggests that CAMKK1 overexpression in mesenchymal stem cells can potentiate cardiac repair via the modulation of secreted paracrine acting factors

MSC-treatment of Parkinson’s Disease: A New Mechanism Uncovered!

A new study suggests that protection against axonal defects represents a new mechanism involved in MSC-treatment of early stage Parkinson’s Disease

Successful First in Man Trial for MSC-based Cartilage Repair

Researchers report on a successful cartilage repair trial using a simple strategy involving mesenchymal stem cell and patient-derived chondrocytes

Phase II for Allogeneic BM-MSC Treatment of Aplastic Anemia!

The results of a new trial suggest that allogeneic bone marrow-derived mesenchymal stem cells may represent an effective means to treat a bone marrow failure disorder

HIF-MSC Exosomes: An Efficient and Effective Strategy to Promote Angiogenesis?

A new study indicates that exosomes derived from stem cells overexpressing the HIF-1α transcription factor can promote angiogenesis in vitro and in vivo

MSC-based Neo Islets: The Future of Long Term Diabetes Control?

A new study describes how Neo Islets composed of mesenchymal stem cells and allogeneic islet cells may be the future of type I diabetes treatment

Pages

Subscribe to RSS - Mesenchymal Stem Cells